American Century Companies’s OnKure Therapeutics OKUR Stock Holding History
Bought
Maintained
Sold
Other funds holding OKUR
RCM
BI
ACA
SG
ACM
VC
VPC
TECP
American Century Companies's OKUR Position: Q2 2026 in Review
American Century Companies opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 23,077 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #2827 among its holdings. This is a return to the name: American Century Companies previously reported a position in OKUR as recently as Q1 2024.
American Century Companies first reported a position in OKUR in Q4 2023 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.
- American Century Companies held 23,077 shares of OnKure Therapeutics worth $105K as of Q2 2026.
- OnKure Therapeutics was a new American Century Companies position in Q2 2026.
- OnKure Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2827 holding.
- American Century Companies first reported a position in OnKure Therapeutics in Q4 2023 and has held it in 3 quarters since.
- 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.